Acinetobacter: A potential reservoir and dispenser for β-lactamases

References

• Afzal-Shah M, Woodford N, Livermore DM. (2001). Characterization of OXA-25, OXA-26, and OXA-27, molecular class D β-lactamases associated with carbapenem resistance in clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother, 45, 583–588.
   PubMed Web of Science ®Google Scholar
• Alsultan AA, Hamouda A, Evans BA, Amyes SG. (2009). Acinetobacter baumannii: emergence of four strains with novel blaOXA-51-like genes in patients with diabetes mellitus. J Chemother, 21, 290–295.
   PubMed Web of Science ®Google Scholar
• Ambler RP. (1980). The structure of β-lactamases. Philos Trans R Soc Lond, B, Biol Sci, 289, 321–331.
   PubMed Web of Science ®Google Scholar
• Anandham R, Weon HY, Kim SJ, Kim YS, Kim BY, Kwon SW. (2010). Acinetobacter brisouii sp. nov., isolated from a wetland in Korea. J Microbiol, 48, 36–39.
   PubMedGoogle Scholar
• Audureau A. (1940). Etude du genre Moraxella. Ann Inst Pasteur, 64, 126–166.
   Google Scholar
• Baumann P, Doudoroff M, Stanier RY. (1968). A study of the Moraxella group. II. Oxidative-negative species (genus Acinetobacter). J Bacteriol, 95, 1520–1541.
   PubMed Web of Science ®Google Scholar
• Beceiro A, Dominguez L, Ribera A, Vila J, Molina F, Villanueva R, Eiros JM, Bou G. (2004). Molecular characterization of the gene encoding a new AmpC β-lactamase in a clinical strain of acinetobacter genomic species 3. Antimicrob Agents Chemother, 48, 1374–1378.
   PubMedGoogle Scholar
• Beceiro A, Pérez-Llarena FJ, Pérez A, Tomás Mdel M, Fernández A, Mallo S, Villanueva R, Bou G. (2007). Molecular characterization of the gene encoding a new AmpC β-lactamase in Acinetobacter baylyi. J Antimicrob Chemother, 59, 996–1000.
   PubMedGoogle Scholar
• Beceiro A, Pérez A, Fernández-Cuenca F, Martínez-Martínez L, Pascual A, Vila J, Rodríguez-Baño J, Cisneros JM, Pachón J, Bou G; and the Spanish Group for Nosocomial Infection (GEIH). (2009). Genetic variability among ampC genes from acinetobacter genomic species 3. Antimicrob Agents Chemother, 53, 1177–1184.
   PubMedGoogle Scholar
• Beijerinck MW. (1911). Pigments as products of oxidation by bacterial action. Proc Royal Acad Sci 13, 1066–1077.
   Google Scholar
• Berlau J, Aucken HM, Houang E, Pitt TL. (1999a). Isolation of Acinetobacter spp. including A. baumannii from vegetables: implications for hospital-acquired infections. J Hosp Infect, 42, 201–204.
   PubMed Web of Science ®Google Scholar
• Berlau J, Aucken H, Malnick H, Pitt T. (1999b). Distribution of Acinetobacter species on skin of healthy humans. Eur J Clin Microbiol Infect Dis, 18, 179–183.
   PubMed Web of Science ®Google Scholar
• Bertini A, Poirel L, Bernabeu S, Fortini D, Villa L, Nordmann P, Carattoli A. (2007). Multicopy blaOXA-58 gene as a source of high-level resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother, 51, 2324–2328.
   PubMedGoogle Scholar
• Bertini A, Poirel L, Mugnier PD, Villa L, Nordmann P, Carattoli A. (2010). Characterization and PCR-based replicon typing of resistance plasmids in Acinetobacter baumannii. Antimicrob Agents Chemother, 54, 4168–4177.
   PubMed Web of Science ®Google Scholar
• Bogaerts P, Cuzon G, Naas T, Bauraing C, Deplano A, Lissoir B, Nordmann P, Glupczynski Y. (2008). Carbapenem-resistant Acinetobacter baumannii isolates expressing the blaOXA-23 gene associated with ISAba4 in Belgium. Antimicrob Agents Chemother, 52, 4205–4206.
   PubMedGoogle Scholar
• Bogaerts P, Naas T, El Garch F, Cuzon G, Deplano A, Delaire T, Huang TD, Lissoir B, Nordmann P, Glupczynski Y. (2010). GES extended-spectrum ß-lactamases in Acinetobacter baumannii isolates in Belgium. Antimicrob Agents Chemother, 54, 4872–4878.
   PubMedGoogle Scholar
• Bonnet R, Marchandin H, Chanal C, Sirot D, Labia R, De Champs C, Jumas-Bilak E, Sirot J. (2002). Chromosome-encoded class D β-lactamase OXA-23 in Proteus mirabilis. Antimicrob Agents Chemother, 46, 2004–2006.
   PubMed Web of Science ®Google Scholar
• Bonnin RA, Potron A, Poirel L, Lecuyer H, Neri R, Nordmann P. (2011a). PER-7, an extended-spectrum β-lactamase with increased activity toward broad-spectrum cephalosporins in Acinetobacter baumannii. Antimicrob Agents Chemother, 55, 2424–2427.
   PubMedGoogle Scholar
• Bonnin RA, Nordmann P, Potron A, Lecuyer H, Zahar JR, Poirel L. (2011b). Carbapenem-hydrolyzing GES-type extended-spectrum β-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother, 55, 349–354.
   PubMed Web of Science ®Google Scholar
• Bou G, Martínez-Beltrán J. (2000). Cloning, nucleotide sequencing, and analysis of the gene encoding an AmpC β-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother, 44, 428–432.
   PubMed Web of Science ®Google Scholar
• Bou G, Oliver A, Martínez-Beltrán J. (2000). OXA-24, a novel class D β-lactamase with carbapenemase activity in an Acinetobacter baumannii clinical strain. Antimicrob Agents Chemother, 44, 1556–1561.
   PubMed Web of Science ®Google Scholar
• Bouvet PJ, Grimont PA. (1986). Taxonomy of the genus Acinetobacter with the recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov., and Acinetobacter junii sp. nov., and emended description of Acinetobacter calcoaceticus and Acinetobacter lwoffii. Int J Syst Bacteriol, 36, 228–240.
   Google Scholar
• Bouvet PJ, Jeanjean S. (1989). Delineation of new proteolytic genomic species in the genus Acinetobacter. Res Microbiol, 140, 291–299.
   PubMedGoogle Scholar
• Bradford PA. (2001). Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev, 14, 933–951.
   PubMed Web of Science ®Google Scholar
• Brisou J, Prevot AR. (1954). [Studies on bacterial taxonomy. X. The revision of species under Acromobacter group]. Ann Inst Pasteur (Paris), 86, 722–728.
   PubMedGoogle Scholar
• Brown S, Amyes SG. (2005). The sequences of seven class D β-lactamases isolated from carbapenem-resistant Acinetobacter baumannii from four continents. Clin Microbiol Infect, 11, 326–329.
   PubMedGoogle Scholar
• Brown S, Young HK, Amyes SG. (2005). Characterisation of OXA-51, a novel class D carbapenemase found in genetically unrelated clinical strains of Acinetobacter baumannii from Argentina. Clin Microbiol Infect, 11, 15–23.
   PubMed Web of Science ®Google Scholar
• Burman LG, Park JT, Lindström EB, Boman HG. (1973). Resistance of Escherichia coli to penicillins: identification of the structural gene for the chromosomal penicillinase. J Bacteriol, 116, 123–130.
   PubMed Web of Science ®Google Scholar
• Carr EL, Kämpfer P, Patel BK, Gürtler V, Seviour RJ. (2003). Seven novel species of Acinetobacter isolated from activated sludge. Int J Syst Evol Microbiol, 53, 953–963.
   PubMedGoogle Scholar
• Celenza G, Pellegrini C, Caccamo M, Segatore B, Amicosante G, Perilli M. (2006). Spread of blaCTX-M-type and blaPER-2 β-lactamase genes in clinical isolates from Bolivian hospitals. J Antimicrob Chemother, 57, 975–978.
   PubMed Web of Science ®Google Scholar
• Chen TL, Lee YT, Kuo SC, Hsueh PR, Chang FY, Siu LK, Ko WC, Fung CP. (2010). Emergence and Distribution of Plasmids Bearing the blaOXA-51-like gene with an upstream ISAba1 in carbapenem-resistant Acinetobacter baumannii isolates in Taiwan. Antimicrob Agents Chemother, 54, 4575–4581.
   PubMed Web of Science ®Google Scholar
• Choury D, Szajnert MF, Joly-Guillou ML, Azibi K, Delpech M, Paul G. (2000). Nucleotide sequence of the blaRTG-2 (CARB-5) gene and phylogeny of a new group of carbenicillinases. Antimicrob Agents Chemother, 44, 1070–1074.
   PubMedGoogle Scholar
• Chu YW, Afzal-Shah M, Houang ET. Palepou MI, Lyon DJ, Woodford N, Livermore DM. (2001). IMP-4, a novel metallo-β-lactamase from nosocomial Acinetobacter spp. collected in Hong Kong between 1994 and 1998. Antimicrob Agents Chemother, 45, 710–714.
   PubMed Web of Science ®Google Scholar
• Chu YW, Cheung TK, Chu MY, Lo JY, Dijkshoorn L. (2009). OXA-23-type imipenem resistance in Acinetobacter baumannii in Hong Kong. Int J Antimicrob Agents, 34, 285–286.
   PubMedGoogle Scholar
• Corvec S, Caroff N, Espaze E, Giraudeau C, Drugeon H, Reynaud A. (2003). AmpC cephalosporinase hyperproduction in Acinetobacter baumannii clinical strains. J Antimicrob Chemother, 52, 629–635.
   PubMed Web of Science ®Google Scholar
• Corvec S, Poirel L, Naas T, Drugeon H, Nordmann P. (2007). Genetics and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-23 in Acinetobacter baumannii. Antimicrob Agents Chemother, 51, 1530–1533.
   PubMedGoogle Scholar
• Da Silva GJ, Correia M, Vital C, Ribeiro G, Sousa JC, Leitão R, Peixe L, Duarte A. (2002). Molecular characterization of blaIMP-5, a new integron-borne metallo-β-lactamase gene from an Acinetobacter baumannii nosocomial isolate in Portugal. FEMS Microbiol Lett, 215, 33–39.
   PubMedGoogle Scholar
• Datta N, Kontomichalou P. (1965). Penicillinase synthesis controlled by infectious R factors in Enterobacteriaceae. Nature, 208, 239–241.
   PubMed Web of Science ®Google Scholar
• Dent LL, Marshall DR, Pratap S, Hulette RB. (2010). Multidrug resistant Acinetobacter baumannii: a descriptive study in a city hospital. BMC Infect Dis, 10, 196.
   PubMed Web of Science ®Google Scholar
• Devaud M, Kayser FH, Bächi B. (1982). Transposon-mediated multiple antibiotic resistance in Acinetobacter strains. Antimicrob Agents Chemother, 22, 323–329.
   PubMedGoogle Scholar
• Di Cello F, Pepi M, Baldi F, Fani R. (1997). Molecular characterization of an n-alkane-degrading bacterial community and identification of a new species, Acinetobacter venetianus. Res Microbiol, 148, 237–249.
   PubMed Web of Science ®Google Scholar
• Dijkshoorn L, Nemec A, Seifert H. (2007). An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol, 5, 939–951.
   PubMed Web of Science ®Google Scholar
• Donald HM, Scaife W, Amyes SG, Young HK. (2000). Sequence analysis of ARI-1, a novel OXA β-lactamase, responsible for imipenem resistance in Acinetobacter baumannii 6B92. Antimicrob Agents Chemother, 44, 196–199.
   PubMed Web of Science ®Google Scholar
• Endimiani A, Luzzaro F, Migliavacca R, Mantengoli E, Hujer AM, Hujer KM, Pagani L, Bonomo RA, Rossolini GM, Toniolo A. (2007). Spread in an Italian hospital of a clonal Acinetobacter baumannii strain producing the TEM-92 extended-spectrum β-lactamase. Antimicrob Agents Chemother, 51, 2211–2214.
   PubMedGoogle Scholar
• Espinal P, Fugazza G, López Y, Kasma M, Lerman Y, Malhotra-Kumar S, Goosens H, Carmeli Y, Vila J. (2011). Dissemination of the NDM-2-producing Acinetobacter baumannii clone in an Israeli Rehabilitation Center. Antimicrob Agents Chemother (Epub ahead of print).
   Google Scholar
• Evans BA, Brown S, Hamouda A, Findlay J, Amyes SG. (2007). Eleven novel OXA-51-like enzymes from clinical isolates of Acinetobacter baumannii. Clin Microbiol Infect, 13, 1137–1138.
   PubMedGoogle Scholar
• Evans BA, Hamouda A, Towner KJ, Amyes SG. (2010). Novel genetic context of multiple blaOXA-58 genes in Acinetobacter genospecies 3. J Antimicrob Chemother, 65, 1586–1588.
   PubMedGoogle Scholar
• Figueiredo S, Poirel L, Papa A, Koulourida V, Nordmann P. (2008). First identification of VIM-4 metallo-β-lactamase in Acinetobacter spp. Clin Microbiol Infect, 14, 289–290.
   PubMedGoogle Scholar
• Figueiredo S, Poirel L, Papa A, Koulourida V, Nordmann P. (2009). Overexpression of the naturally occurring blaOXA-51 gene in Acinetobacter baumannii mediated by novel insertion sequence ISAba9. Antimicrob Agents Chemother, 53, 4045–4047.
   PubMed Web of Science ®Google Scholar
• Figueiredo S, Poirel L, Seifert H, Mugnier P, Benhamou D, Nordmann P. (2010). OXA-134, a naturally occurring carbapenem-hydrolyzing class D β-lactamase from Acinetobacter lwoffii. Antimicrob Agents Chemother, 54, 5372–5375.
   PubMedGoogle Scholar
• Gales AC, Tognim MC, Reis AO, Jones RN, Sader HS. (2003). Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital. Diagn Microbiol Infect Dis, 45, 77–79.
   PubMed Web of Science ®Google Scholar
• Gerner-Smidt P, Tjernberg I, Ursing J. (1991). Reliability of phenotypic tests for identification of Acinetobacter species. J Clin Microbiol, 29, 277–282.
   PubMed Web of Science ®Google Scholar
• Gerner-Smidt P, Tjernberg I. (1993). Acinetobacter in Denmark: II. Molecular studies of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex. APMIS, 101, 826–832.
   PubMedGoogle Scholar
• Giannouli M, Tomasone F, Agodi A, Vahaboglu H, Daoud Z, Triassi M, Tsakris A, Zarrilli R. (2009). Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii strains in intensive care units of multiple Mediterranean hospitals. J Antimicrob Chemother, 63, 828–830.
   PubMedGoogle Scholar
• Goldstein FW, Labigne-Roussel A, Gerbaud G, Carlier C, Collatz E, Courvalin P. (1983). Transferable plasmid-mediated antibiotic resistance in Acinetobacter. Plasmid, 10, 138–147.
   PubMed Web of Science ®Google Scholar
• Gulati A, Vyas P, Rahi P, Kasana RC. (2009). Plant growth-promoting and rhizosphere-competent Acinetobacter rhizosphaerae strain BIHB 723 from the cold deserts of the Himalayas. Curr Microbiol, 58, 371–377.
   PubMed Web of Science ®Google Scholar
• Hansson K, Sundström L, Pelletier A, Roy PH. (2002). IntI2 integron integrase in Tn7. J Bacteriol, 184, 1712–1721.
   PubMed Web of Science ®Google Scholar
• Henwood CJ, Gatward T, Warner M, James D, Stockdale MW, Spence RP, Towner KJ, Livermore DM, Woodford N. (2002). Antibiotic resistance among clinical isolates of Acinetobacter in the UK, and in vitro evaluation of tigecycline (GAR-936). J Antimicrob Chemother, 49, 479–487.
   PubMed Web of Science ®Google Scholar
• Higgins PG, Poirel L, Lehmann M, Nordmann P, Seifert H. (2009). OXA-143, a novel carbapenem-hydrolyzing class D β-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother, 53, 5035–5038.
   PubMed Web of Science ®Google Scholar
• Houang ET, Chu YW, Leung CM, Chu KY, Berlau J, Ng KC, Cheng AF. (2001). Epidemiology and infection control implications of Acinetobacter spp. in Hong Kong. J Clin Microbiol, 39, 228–234.
   PubMedGoogle Scholar
• Huang LY, Lu PL, Chen TL, Chang FY, Fung CP, Siu LK. (2010). Molecular characterization of β-lactamase genes and their genetic structures in Acinetobacter genospecies 3 isolates in Taiwan. Antimicrob Agents Chemother, 54, 2699–2703.
   PubMedGoogle Scholar
• Hujer KM, Hamza NS, Hujer AM, Perez F, Helfand MS, Bethel CR, Thomson JM, Anderson VE, Barlow M, Rice LB, Tenover FC, Bonomo RA. (2005). Identification of a new allelic variant of the Acinetobacter baumannii cephalosporinase, ADC-7 β-lactamase: defining a unique family of class C enzymes. Antimicrob Agents Chemother, 49, 2941–2948.
   PubMed Web of Science ®Google Scholar
• Héritier C, Poirel L, Aubert D, Nordmann P. (2003). Genetic and functional analysis of the chromosome-encoded carbapenem-hydrolyzing oxacillinase OXA-40 of Acinetobacter baumannii. Antimicrob Agents Chemother, 47, 268–273.
   PubMed Web of Science ®Google Scholar
• Héritier C, Poirel L, Nordmann P. (2006). Cephalosporinase over-expression resulting from insertion of ISAba1 in Acinetobacter baumannii. Clin Microbiol Infect, 12, 123–130.
   PubMed Web of Science ®Google Scholar
• Jacoby G, Bush K. (2011). β-Lactamase classification and amino acid sequences for TEM, SHV and OXA extended-spectrum and inhibitor resistant enzymes. http://www.lahey.org/Studies/. Accessed on 3 July 2011.
   Google Scholar
• Jacoby GA. (2009). AmpC β-lactamases. Clin Microbiol Rev, 22, 161–182.
   PubMed Web of Science ®Google Scholar
• Kaase M, Nordmann P, Wichelhaus TA, Gatermann SG, Bonnin RA, Poirel L. (2011). NDM-2 carbapenemase in Acinetobacter baumannii from Egypt. J Antimicrob Chemother, 66, 1260–1262.
   PubMed Web of Science ®Google Scholar
• Kang YS, Jung J, Jeon CO, Park W. (2011). Acinetobacter oleivorans sp. nov. is capable of adhering to and growing on diesel-oil. J Microbiol, 49, 29–34.
   PubMed Web of Science ®Google Scholar
• Karah N, Haldorsen B, Hegstad K, Simonsen GS, Sundsfjord A, Samuelsen Ø; Norwegian Study Group of Acinetobacter. (2011). Species identification and molecular characterization of Acinetobacter spp. blood culture isolates from Norway. J Antimicrob Chemother, 66, 738–744.
   PubMed Web of Science ®Google Scholar
• Karthikeyan K, Thirunarayan MA, Krishnan P. (2010). Coexistence of blaOXA-23 with blaNDM-1 and armA in clinical isolates of Acinetobacter baumannii from India. J Antimicrob Chemother, 65, 2253–2254.
   PubMed Web of Science ®Google Scholar
• Kilic A, Li H, Mellmann A, Basustaoglu AC, Kul M, Senses Z, Aydogan H, Stratton CW, Harmsen D, Tang YW. (2008). Acinetobacter septicus sp. nov. association with a nosocomial outbreak of bacteremia in a neonatal intensive care unit. J Clin Microbiol, 46, 902–908.
   PubMed Web of Science ®Google Scholar
• Kim CK, Lee Y, Lee H, Woo GJ, Song W, Kim MN, Lee WG, Jeong SH, Lee K, Chong Y. (2010). Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea: emergence of a novel OXA-182. Diagn Microbiol Infect Dis, 68, 432–438.
   PubMed Web of Science ®Google Scholar
• Kim D, Baik KS, Kim MS, Park SC, Kim SS, Rhee MS, Kwak YS, Seong CN. (2008). Acinetobacter soli sp. nov., isolated from forest soil. J Microbiol, 46, 396–401.
   PubMed Web of Science ®Google Scholar
• Koh TH, Sng LH, Wang GC, Hsu LY, Zhao Y. (2007). IMP-4 and OXA β-lactamases in Acinetobacter baumannii from Singapore. J Antimicrob Chemother, 59, 627–632.
   PubMedGoogle Scholar
• Lee HJ, Lee SS. (2010). Acinetobacter kyonggiensis sp. nov., a ß-glucosidase-producing bacterium, isolated from sewage treatment plant. J Microbiol, 48, 754–759.
   PubMedGoogle Scholar
• Lee K, Kim CK, Hong SG, Choi J, Song S, Koh E, Yong D, Jeong SH, Yum JH, Docquier JD, Rossolini GM, Chong Y. (2010). Characteristics of clinical isolates of Acinetobacter genomospecies 10 carrying two different metallo-β-lactamases. Int J Antimicrob Agents, 36, 259–263.
   PubMedGoogle Scholar
• Lee K, Kim MN, Choi TY, Cho SE, Lee S, Whang DH, Yong D, Chong Y, Woodford N, Livermore DM; KONSAR Group. (2009a). Wide dissemination of OXA-type carbapenemases in clinical Acinetobacter spp. isolates from South Korea. Int J Antimicrob Agents, 33, 520–524.
   PubMedGoogle Scholar
• Lee K, Yum JH, Yong D, Lee HM, Kim HD, Docquier JD, Rossolini GM, Chong Y. (2005). Novel acquired metallo-β-lactamase gene, blaSIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob Agents Chemother, 49, 4485–4491.
   PubMed Web of Science ®Google Scholar
• Lee MF, Peng CF, Hsu HJ, Chen YH. (2008). Molecular characterisation of the metallo-β-lactamase genes in imipenem-resistant Gram-negative bacteria from a university hospital in southern Taiwan. Int J Antimicrob Agents, 32, 475–480.
   PubMedGoogle Scholar
• Lee JS, Lee KC, Kim KK, Hwang IC, Jang C, Kim NG, Yeo WH, Kim BS, Yu YM, Ahn JS. (2009b). Acinetobacter antiviralis sp. nov., from Tobacco plant roots. J Microbiol Biotechnol, 19, 250–256.
   PubMedGoogle Scholar
• Lee Y, Kim CK, Lee H, Jeong SH, Yong D, Lee K. (2011). A novel insertion sequence, ISAba10, inserted into ISAba1 adjacent to the blaOXA-23 gene and disrupting the outer membrane protein gene carO in Acinetobacter baumannii. Antimicrob Agents Chemother, 55, 361–363.
   PubMedGoogle Scholar
• Lee YT, Turton JF, Chen TL, Wu RC, Chang WC, Fung CP, Chen CP, Cho WL, Huang LY, Siu LK. (2009c). First identification of blaOXA-51-like in non-baumannii Acinetobacter spp. J Chemother, 21, 514–520.
   PubMed Web of Science ®Google Scholar
• Lolans K, Rice TW, Munoz-Price LS, Quinn JP. (2006). Multicity outbreak of carbapenem-resistant Acinetobacter baumannii isolates producing the carbapenemase OXA-40. Antimicrob Agents Chemother, 50, 2941–2945.
   PubMed Web of Science ®Google Scholar
• Mahillon J, Chandler M. (1998). Insertion sequences. Microbiol Mol Biol Rev, 62, 725–774.
   PubMed Web of Science ®Google Scholar
• Mammeri H, Poirel L, Mangeney N, Nordmann P. (2003). Chromosomal integration of a cephalosporinase gene from Acinetobacter baumannii into Oligella urethralis as a source of acquired resistance to β-lactams. Antimicrob Agents Chemother, 47, 1536–1542.
   PubMedGoogle Scholar
• Marqué S, Poirel L, Héritier C, Brisse S, Blasco MD, Filip R, Coman G, Naas T, Nordmann P. (2005). Regional occurrence of plasmid-mediated carbapenem-hydrolyzing oxacillinase OXA-58 in Acinetobacter spp. in Europe. J Clin Microbiol, 43, 4885–4888.
   PubMed Web of Science ®Google Scholar
• Matthew M, Harris AM. (1976). Identification of β-lactamases by analytical isoelectric focusing: correlation with bacterial taxonomy. J Gen Microbiol, 94, 55–67.
   PubMedGoogle Scholar
• Mazel D. (2006). Integrons: agents of bacterial evolution. Nat Rev Microbiol, 4, 608–620.
   PubMed Web of Science ®Google Scholar
• Mendes RE, Bell JM, Turnidge JD, Castanheira M, Deshpande LM, Jones RN. (2009a). Codetection of blaOXA-23-like gene (blaOXA-133) and blaOXA-58 in Acinetobacter radioresistens: report from the SENTRY antimicrobial surveillance program. Antimicrob Agents Chemother, 53, 843–844.
   PubMedGoogle Scholar
• Mendes RE, Bell JM, Turnidge JD, Castanheira M, Jones RN. (2009b). Emergence and widespread dissemination of OXA-23, -24/40 and -58 carbapenemases among Acinetobacter spp. in Asia-Pacific nations: report from the SENTRY Surveillance Program. J Antimicrob Chemother, 63, 55–59.
   PubMed Web of Science ®Google Scholar
• Merkier AK, Centrón D. (2006). blaOXA-51-type β-lactamase genes are ubiquitous and vary within a strain in Acinetobacter baumannii. Int J Antimicrob Agents, 28, 110–113.
   PubMed Web of Science ®Google Scholar
• Mitsuhashi S, Inoue M. (1981). Mechanisms of resistance to β-lactam antibiotics. In: Mitsuhashi S, ed. β-lactam antibiotics. New York: Springer-Verlag, 41–56.
   Google Scholar
• Moubareck C, Brémont S, Conroy MC, Courvalin P, Lambert T. (2009). GES-11, a novel integron-associated GES variant in Acinetobacter baumannii. Antimicrob Agents Chemother, 53, 3579–3581.
   PubMed Web of Science ®Google Scholar
• Mugnier PD, Poirel L, Naas T, Nordmann P. (2010). Worldwide dissemination of the blaOXA-23 carbapenemase gene of Acinetobacter baumannii. Emerging Infect Dis, 16, 35–40.
   PubMed Web of Science ®Google Scholar
• Mugnier PD, Poirel L, Nordmann P. (2009). Functional analysis of insertion sequence ISAba1, responsible for genomic plasticity of Acinetobacter baumannii. J Bacteriol, 191, 2414–2418.
   PubMedGoogle Scholar
• Naas T, Bogaerts P, Bauraing C, Degheldre Y, Glupczynski Y, Nordmann P. (2006a). Emergence of PER and VEB extended-spectrum β-lactamases in Acinetobacter baumannii in Belgium. J Antimicrob Chemother, 58, 178–182.
   PubMed Web of Science ®Google Scholar
• Naas T, Coignard B, Carbonne A, Blanckaert K, Bajolet O, Bernet C, Verdeil X, Astagneau P, Desenclos JC, Nordmann P; French Nosocomial Infection Early Warning Investigation and Surveillance Network. (2006b). VEB-1 Extended-spectrum β-lactamase-producing Acinetobacter baumannii, France. Emerging Infect Dis, 12, 1214–1222.
   PubMedGoogle Scholar
• Naas T, Namdari F, Réglier-Poupet H, Poyart C, Nordmann P. (2007). Panresistant extended-spectrum β-lactamase SHV-5-producing Acinetobacter baumannii from New York City. J Antimicrob Chemother, 60, 1174–1176.
   PubMed Web of Science ®Google Scholar
• Naas T, Nordmann P. (1999). OXA-type β-lactamases. Curr Pharm Des, 5, 865–879.
   PubMed Web of Science ®Google Scholar
• Naas T, Poirel L, Nordmann P. (2008). Minor extended-spectrum β-lactamases. Clin Microbiol Infect, 14 Suppl 1, 42–52.
   PubMedGoogle Scholar
• Nagano N, Nagano Y, Cordevant C, Shibata N, Arakawa Y. (2004). Nosocomial transmission of CTX-M-2 β-lactamase-producing Acinetobacter baumannii in a neurosurgery ward. J Clin Microbiol, 42, 3978–3984.
   PubMed Web of Science ®Google Scholar
• Naiemi NA, Duim B, Savelkoul PH, Spanjaard L, de Jonge E, Bart A, Vandenbroucke-Grauls CM, de Jong MD. (2005). Widespread transfer of resistance genes between bacterial species in an intensive care unit: implications for hospital epidemiology. J Clin Microbiol, 43, 4862–4864.
   PubMed Web of Science ®Google Scholar
• Navia MM, Ruiz J, Vila J. (2002). Characterization of an integron carrying a new class D β-lactamase (OXA-37) in Acinetobacter baumannii. Microb Drug Resist, 8, 261–265.
   PubMedGoogle Scholar
• Nemec A, De Baere T, Tjernberg I, Vaneechoutte M, van der Reijden TJ, Dijkshoorn L. (2001). Acinetobacter ursingii sp. nov. and Acinetobacter schindleri sp. nov., isolated from human clinical specimens. Int J Syst Evol Microbiol, 51, 1891–1899.
   PubMedGoogle Scholar
• Nemec A, Dijkshoorn L, Cleenwerck I, De Baere T, Janssens D, Van Der Reijden TJ, Jezek P, Vaneechoutte M. (2003). Acinetobacter parvus sp. nov., a small-colony-forming species isolated from human clinical specimens. Int J Syst Evol Microbiol, 53, 1563–1567.
   PubMedGoogle Scholar
• Nemec A, Musílek M, Maixnerová M, De Baere T, van der Reijden TJ, Vaneechoutte M, Dijkshoorn L. (2009). Acinetobacter beijerinckii sp. nov. and Acinetobacter gyllenbergii sp. nov., haemolytic organisms isolated from humans. Int J Syst Evol Microbiol, 59, 118–124.
   PubMed Web of Science ®Google Scholar
• Nemec A, Musílek M, Sedo O, De Baere T, Maixnerová M, van der Reijden TJ, Zdráhal Z, Vaneechoutte M, Dijkshoorn L. (2010). Acinetobacter bereziniae sp. nov. and Acinetobacter guillouiae sp. nov., to accommodate Acinetobacter genomic species 10 and 11, respectively. Int J Syst Evol Microbiol, 60, 896–903.
   PubMedGoogle Scholar
• Nemec A, Krizova L, Maixnerova M, van der Reijden TJ, Deschaght P, Passet V, Vaneechoutte M, Brisse S, Dijkshoorn L. (2011). Genotypic and phenotypic characterization of the Acinetobacter calcoaceticus-Acinetobacter baumannii complex with the proposal of Acinetobacter pittii sp. nov. (formerly Acinetobacter genomic species 3) and Acinetobacter nosocomialis sp. nov. (formerly Acinetobacter genomic species 13TU). Res Microbiol, 162, 393–404.
   PubMed Web of Science ®Google Scholar
• Nishio H, Komatsu M, Shibata N, Shimakawa K, Sueyoshi N, Ura T, Satoh K, Toyokawa M, Nakamura T, Wada Y, Orita T, Kofuku T, Yamasaki K, Sakamoto M, Kinoshita S, Aihara M, Arakawa Y. (2004). Metallo-β-lactamase-producing gram-negative bacilli: laboratory-based surveillance in cooperation with 13 clinical laboratories in the Kinki region of Japan. J Clin Microbiol, 42, 5256–5263.
   PubMedGoogle Scholar
• Nishimura Y, Ino T, Iizuka H (1988). Acinetobacter radioresistens sp. nov. isolated from cotton and soil. Int J Syst Bacteriol, 38, 209–211.
   Google Scholar
• Nordmann P, Guibert M. (1998). Extended-spectrum β-lactamases in Pseudomonas aeruginosa. J Antimicrob Chemother, 42, 128–131.
   PubMed Web of Science ®Google Scholar
• Nordmann P, Mammeri H. (2007). Extended-spectrum cephalosporinases: structure, detection and epidemiology. Future Microbiol, 2, 297–307.
   PubMed Web of Science ®Google Scholar
• Park YK, Choi JY, Jung SI, Park KH, Lee H, Jung DS, Heo ST, Kim SW, Chang HH, Cheong HS, Chung DR, Peck KR, Song JH, Ko KS. (2009). Two distinct clones of carbapenem-resistant Acinetobacter baumannii isolates from Korean hospitals. Diagn Microbiol Infect Dis, 64, 389–395.
   PubMed Web of Science ®Google Scholar
• Paterson DL, Bonomo RA. (2005). Extended-spectrum β-lactamases: a clinical update. Clin Microbiol Rev, 18, 657–686.
   PubMed Web of Science ®Google Scholar
• Paton R, Miles RS, Hood J, Amyes SG, Miles RS, Amyes SG. (1993). ARI 1: β-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int J Antimicrob Agents, 2, 81–87.
   PubMedGoogle Scholar
• Peleg AY, Franklin C, Walters LJ, Bell JM, Spelman DW. (2006). OXA-58 and IMP-4 carbapenem-hydrolyzing β-lactamases in an Acinetobacter junii blood culture isolate from Australia. Antimicrob Agents Chemother, 50, 399–400.
   PubMed Web of Science ®Google Scholar
• Peleg AY, Seifert H, Paterson DL. (2008). Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev, 21, 538–582.
   PubMed Web of Science ®Google Scholar
• Perez F, Hujer AM, Hujer KM, Decker BK, Rather PN, Bonomo RA. (2007). Global challenge of multidrug-resistant Acinetobacter baumannii. Antimicrob Agents Chemother, 51, 3471–3484.
   PubMed Web of Science ®Google Scholar
• Pfeifer Y, Wilharm G, Zander E, Wichelhaus TA, Göttig S, Hunfeld KP, Seifert H, Witte W, Higgins PG. (2011). Molecular characterization of blaNDM-1 in an Acinetobacter baumannii strain isolated in Germany in 2007. J Antimicrob Chemother, 66, 1998–2001.
   PubMed Web of Science ®Google Scholar
• Poirel L, Corvec S, Rapoport M, Mugnier P, Petroni A, Pasteran F, Faccone D, Galas M, Drugeon H, Cattoir V, Nordmann P. (2007a). Identification of the novel narrow-spectrum β-lactamase SCO-1 in Acinetobacter spp. from Argentina. Antimicrob Agents Chemother, 51, 2179–2184.
   PubMedGoogle Scholar
• Poirel L, Figueiredo S, Cattoir V, Carattoli A, Nordmann P. (2008a). Acinetobacter radioresistens as a silent source of carbapenem resistance for Acinetobacter spp. Antimicrob Agents Chemother, 52, 1252–1256.
   PubMed Web of Science ®Google Scholar
• Poirel L, Mansour W, Bouallegue O, Nordmann P. (2008b). Carbapenem-resistant Acinetobacter baumannii isolates from Tunisia producing the OXA-58-like carbapenem-hydrolyzing oxacillinase OXA-97. Antimicrob Agents Chemother, 52, 1613–1617.
   PubMedGoogle Scholar
• Poirel L, Marqué S, Héritier C, Segonds C, Chabanon G, Nordmann P. (2005). OXA-58, a novel class D β-lactamase involved in resistance to carbapenems in Acinetobacter baumannii. Antimicrob Agents Chemother, 49, 202–208.
   PubMed Web of Science ®Google Scholar
• Poirel L, Menuteau O, Agoli N, Cattoen C, Nordmann P. (2003). Outbreak of extended-spectrum β-lactamase VEB-1-producing isolates of Acinetobacter baumannii in a French hospital. J Clin Microbiol, 41, 3542–3547.
   PubMed Web of Science ®Google Scholar
• Poirel L, Mugnier PD, Toleman MA, Walsh TR, Rapoport MJ, Petroni A, Nordmann P. (2009). ISCR2, another vehicle for blaVEB gene acquisition. Antimicrob Agents Chemother, 53, 4940–4943.
   PubMedGoogle Scholar
• Poirel L, Naas T, Nordmann P. (2010). Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrob Agents Chemother, 54, 24–38.
   PubMed Web of Science ®Google Scholar
• Poirel L, Nordmann P. (2006). Genetic structures at the origin of acquisition and expression of the carbapenem-hydrolyzing oxacillinase gene blaOXA-58 in Acinetobacter baumannii. Antimicrob Agents Chemother, 50, 1442–1448.
   PubMed Web of Science ®Google Scholar
• Poirel L, Pitout JD, Nordmann P. (2007b). Carbapenemases: molecular diversity and clinical consequences. Future Microbiol, 2, 501–512.
   PubMed Web of Science ®Google Scholar
• Potron A, Poirel L, Croizé J, Chanteperdrix V, Nordmann P. (2009). Genetic and biochemical characterization of the first extended-spectrum CARB-type β-lactamase, RTG-4, from Acinetobacter baumannii. Antimicrob Agents Chemother, 53, 3010–3016.
   PubMedGoogle Scholar
• Queenan AM, Bush K. (2007). Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev, 20, 440–458.
   PubMed Web of Science ®Google Scholar
• Ramirez MS, Adams MD, Bonomo RA, Centrón D, Tolmasky ME. (2011). Genomic analysis of Acinetobacter baumannii A118 by comparison of optical maps: identification of structures related to its susceptibility phenotype. Antimicrob Agents Chemother, 55, 1520–1526.
   PubMed Web of Science ®Google Scholar
• Ramírez MS, Piñeiro S, Centrón D; Argentinian Integron Study Group. (2010). Novel insights about class 2 integrons from experimental and genomic epidemiology. Antimicrob Agents Chemother, 54, 699–706.
   PubMed Web of Science ®Google Scholar
• Ravasi P, Limansky AS, Rodriguez RE, Viale AM, Mussi MA. (2011). ISAba825, a functional insertion sequence modulating genomic plasticity and blaOXA-58 expression in Acinetobacter baumannii. Antimicrob Agents Chemother, 55, 917–920.
   PubMedGoogle Scholar
• Riccio ML, Franceschini N, Boschi L, Caravelli B, Cornaglia G, Fontana R, Amicosante G, Rossolini GM. (2000). Characterization of the metallo-β-lactamase determinant of Acinetobacter baumannii AC-54/97 reveals the existence of blaIMP allelic variants carried by gene cassettes of different phylogeny. Antimicrob Agents Chemother, 44, 1229–1235.
   PubMed Web of Science ®Google Scholar
• Robledo IE, Aquino EE, Santé MI, Santana JL, Otero DM, León CF, Vázquez GJ. (2010). Detection of KPC in Acinetobacter spp. in Puerto Rico. Antimicrob Agents Chemother, 54, 1354–1357.
   PubMed Web of Science ®Google Scholar
• Rodríguez-Martínez JM, Nordmann P, Ronco E, Poirel L. (2010a). Extended-spectrum cephalosporinase in Acinetobacter baumannii. Antimicrob Agents Chemother, 54, 3484–3488.
   PubMedGoogle Scholar
• Rodríguez-Martínez JM, Poirel L, Nordmann P. (2010b). Genetic and functional variability of AmpC-type ß-lactamases from Acinetobacter baumannii. Antimicrob Agents Chemother, 54, 4930–4933.
   PubMed Web of Science ®Google Scholar
• Sato K, Nakae T. (1991). Outer membrane permeability of Acinetobacter calcoaceticus and its implication in antibiotic resistance. J Antimicrob Chemother, 28, 35–45.
   PubMed Web of Science ®Google Scholar
• Segal H, Garny S, Elisha BG. (2005). Is ISABA-1 customized for Acinetobacter? FEMS Microbiol Lett, 243, 425–429.
   PubMed Web of Science ®Google Scholar
• Segal H, Nelson EC, Elisha BG. (2004). Genetic environment and transcription of ampC in an Acinetobacter baumannii clinical isolate. Antimicrob Agents Chemother, 48, 612–614.
   PubMed Web of Science ®Google Scholar
• Seifert H, Baginski R, Schulze A, Pulverer G. (1993a). The distribution of Acinetobacter species in clinical culture materials. Zentralbl Bakteriol, 279, 544–552.
   PubMedGoogle Scholar
• Seifert H, Baginski R, Schulze A, Pulverer G. (1993b). Antimicrobial susceptibility of Acinetobacter species. Antimicrob Agents Chemother, 37, 750–753.
   PubMed Web of Science ®Google Scholar
• Seifert H, Dijkshoorn L, Gerner-Smidt P, Pelzer N, Tjernberg I, Vaneechoutte M. (1997). Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J Clin Microbiol, 35, 2819–2825.
   PubMed Web of Science ®Google Scholar
• Sevillano E, Gallego L, García-Lobo JM. (2009). First detection of the OXA-40 carbapenemase in P. aeruginosa isolates, located on a plasmid also found in A. baumannii. Pathol Biol, 57, 493–495.
   PubMedGoogle Scholar
• Shakil S, Khan AU. (2010). Detection of CTX-M-15-producing and carbapenem-resistant Acinetobacter baumannii strains from urine from an Indian hospital. J Chemother, 22, 324–327.
   PubMed Web of Science ®Google Scholar
• Shibata N, Doi Y, Yamane K, Yagi T, Kurokawa H, Shibayama K, Kato H, Kai K, Arakawa Y. (2003). PCR typing of genetic determinants for metallo-β-lactamases and integrases carried by gram-negative bacteria isolated in Japan, with focus on the class 3 integron. J Clin Microbiol, 41, 5407–5413.
   PubMed Web of Science ®Google Scholar
• Stokes HW, Hall RM. (1989). A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions: integrons. Mol Microbiol, 3, 1669–1683.
   PubMed Web of Science ®Google Scholar
• Tian GB, Adams-Haduch JM, Bogdanovich T, Pasculle AW, Quinn JP, Wang HN, Doi Y. (2011a). Identification of diverse OXA-40 group carbapenemases, including a novel variant, OXA-160, from Acinetobacter baumannii in Pennsylvania. Antimicrob Agents Chemother, 55, 429–432.
   PubMedGoogle Scholar
• Tian GB, Adams-Haduch JM, Taracila M, Bonomo RA, Wang HN, Doi Y. (2011b). Extended-spectrum AmpC in Acinetobacter baumannii; ADC-56 confers resistance to cefepime. Antimicrob Agents Chemother 55, 4922–4925.
   Google Scholar
• Tjernberg I, Ursing J. (1989). Clinical strains of Acinetobacter classified by DNA-DNA hybridization. APMIS, 97, 595–605.
   PubMedGoogle Scholar
• Theaker C, Azadian B, Soni N. (2003). The impact of Acinetobacter baumannii in the intensive care unit. Anaesthesia, 58, 271–274.
   PubMedGoogle Scholar
• Toleman MA, Simm AM, Murphy TA, Gales AC, Biedenbach DJ, Jones RN, Walsh TR. (2002). Molecular characterization of SPM-1, a novel metallo-β-lactamase isolated in Latin America: report from the SENTRY antimicrobial surveillance programme. J Antimicrob Chemother, 50, 673–679.
   PubMed Web of Science ®Google Scholar
• Towner KJ, Levi K, Vlassiadi M; ARPAC Steering Group. (2008). Genetic diversity of carbapenem-resistant isolates of Acinetobacter baumannii in Europe. Clin Microbiol Infect, 14, 161–167.
   PubMedGoogle Scholar
• Tsakris A, Ikonomidis A, Poulou A, Spanakis N, Vrizas D, Diomidous M, Pournaras S, Markou F. (2008). Clusters of imipenem-resistant Acinetobacter baumannii clones producing different carbapenemases in an intensive care unit. Clin Microbiol Infect, 14, 588–594.
   PubMed Web of Science ®Google Scholar
• Tsakris A, Ikonomidis A, Pournaras S, Tzouvelekis LS, Sofianou D, Legakis NJ, Maniatis AN. (2006). VIM-1 metallo-β-lactamase in Acinetobacter baumannii. Emerging Infect Dis, 12, 981–983.
   PubMed Web of Science ®Google Scholar
• Tsakris A, Ikonomidis A, Spanakis N, Pournaras S, Bethimouti K. (2007). Identification of a novel blaOXA-51 variant, blaOXA-92, from a clinical isolate of Acinetobacter baumannii. Clin Microbiol Infect, 13, 348–349.
   PubMedGoogle Scholar
• Turner PJ. (2008). Meropenem activity against European isolates: report on the MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) 2006 results. Diagn Microbiol Infect Dis, 60, 185–192.
   PubMed Web of Science ®Google Scholar
• Turton JF, Ward ME, Woodford N, Kaufmann ME, Pike R, Livermore DM, Pitt TL. (2006a). The role of ISAba1 in expression of OXA carbapenemase genes in Acinetobacter baumannii. FEMS Microbiol Lett, 258, 72–77.
   PubMed Web of Science ®Google Scholar
• Turton JF, Woodford N, Glover J, Yarde S, Kaufmann ME, Pitt TL. (2006b). Identification of Acinetobacter baumannii by detection of the blaOXA-51-like carbapenemase gene intrinsic to this species. J Clin Microbiol, 44, 2974–2976.
   PubMed Web of Science ®Google Scholar
• Vahaboglu H, Budak F, Kasap M, Gacar G, Torol S, Karadenizli A, Kolayli F, Eroglu C. (2006). High prevalence of OXA-51-type class D β-lactamases among ceftazidime-resistant clinical isolates of Acinetobacter spp.: co-existence with OXA-58 in multiple centres. J Antimicrob Chemother, 58, 537–542.
   PubMed Web of Science ®Google Scholar
• Vahaboglu H, Oztürk R, Aygün G, Coskunkan F, Yaman A, Kaygusuz A, Leblebicioglu H, Balik I, Aydin K, Otkun M. (1997). Widespread detection of PER-1-type extended-spectrum β-lactamases among nosocomial Acinetobacter and Pseudomonas aeruginosa isolates in Turkey: a nationwide multicenter study. Antimicrob Agents Chemother, 41, 2265–2269.
   PubMed Web of Science ®Google Scholar
• Vaz-Moreira I, Novo A, Hantsis-Zacharov E, Lopes AR, Gomila M, Nunes OC, Manaia CM, Halpern M. (2011). Acinetobacter rudis sp. nov. isolated from raw milk and raw wastewater. Int J Syst Evol Microbiol, (Epub ahead of print).
   Google Scholar
• Vila J, Marcos A, Marco F, Abdalla S, Vergara Y, Reig R, Gomez-Lus R, Jimenez de Anta T. (1993). In vitro antimicrobial production of β-lactamases, aminoglycoside-modifying enzymes, and chloramphenicol acetyltransferase by and susceptibility of clinical isolates of Acinetobacter baumannii. Antimicrob Agents Chemother, 37, 138–141.
   PubMed Web of Science ®Google Scholar
• Vila J, Navia M, Ruiz J, Casals C. (1997). Cloning and nucleotide sequence analysis of a gene encoding an OXA-derived β-lactamase in Acinetobacter baumannii. Antimicrob Agents Chemother, 41, 2757–2759.
   PubMedGoogle Scholar
• Waley SG. (1992). β-Lactamase: mechanism of action. In: Page MI, ed. The chemistry of β-lactams. London: Chapman and Hall, 198–228.
   Google Scholar
• Walsh TR, Toleman MA, Poirel L, Nordmann P. (2005). Metallo-β-lactamases: the quiet before the storm? Clin Microbiol Rev, 18, 306–325.
   PubMed Web of Science ®Google Scholar
• Walther-Rasmussen J, Høiby N. (2007). Class A carbapenemases. J Antimicrob Chemother, 60, 470–482.
   PubMed Web of Science ®Google Scholar
• Wang H, Guo P, Sun H, Wang H, Yang Q, Chen M, Xu Y, Zhu Y. (2007). Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob Agents Chemother, 51, 4022–4028.
   PubMed Web of Science ®Google Scholar
• Yamamoto M, Nagao M, Matsumura Y, Matsushima A, Ito Y, Takakura S, Ichiyama S. (2011). Interspecies dissemination of a novel class 1 integron carrying blaIMP-19 among Acinetobacter species in Japan. J Antimicrob Chemother, Epub ahead of print.
   Google Scholar
• Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR. (2009). Characterization of a new metallo-β-lactamase gene, blaNDM-1, and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother, 53, 5046–5054.
   PubMed Web of Science ®Google Scholar
• Yoon JH, Kim IG, Oh TK. (2007). Acinetobacter marinus sp. nov. and Acinetobacter seohaensis sp. nov., isolated from sea water of the Yellow Sea in Korea. J Microbiol Biotechnol, 17, 1743–1750.
   PubMed Web of Science ®Google Scholar
• Yum JH, Yi K, Lee H, Yong D, Lee K, Kim JM, Rossolini GM, Chong Y. (2002). Molecular characterization of metallo-β-lactamase-producing Acinetobacter baumannii and Acinetobacter genomospecies 3 from Korea: identification of two new integrons carrying the blaVIM-2 gene cassettes. J Antimicrob Chemother, 49, 837–840.
   PubMedGoogle Scholar
• Zarrilli R, Crispino M, Bagattini M, Barretta E, Di Popolo A, Triassi M, Villari P. (2004). Molecular epidemiology of sequential outbreaks of Acinetobacter baumannii in an intensive care unit shows the emergence of carbapenem resistance. J Clin Microbiol, 42, 946–953.
   PubMed Web of Science ®Google Scholar
• Zhao WH, Hu ZQ. (2010). β-lactamases identified in clinical isolates of Pseudomonas aeruginosa. Crit Rev Microbiol, 36, 245–258.
   PubMed Web of Science ®Google Scholar
• Zhao WH, Hu ZQ. (2011a). IMP-type metallo-ß-lactamases in Gram-negative bacilli: distribution, phylogeny, and association with integrons. Crit Rev Microbiol, 37, 214–226.
   PubMed Web of Science ®Google Scholar
• Zhao WH, Hu ZQ. (2011b). Epidemiology and genetics of VIM-type metallo-ß-lactamases in Gram-negative bacilli. Future Microbiol, 6, 317–333.
   PubMed Web of Science ®Google Scholar
• Zong Z, Lü X, Valenzuela JK, Partridge SR, Iredell J. (2008). An outbreak of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemase in western China. Int J Antimicrob Agents, 31, 50–54.
   PubMedGoogle Scholar